News
The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 ...
Neurological disorders are conditions that affect how the nervous system works. The nervous system sends and receives ...
2d
ScienceAlert on MSNScientists Identify Specific Bacteria Linked to Multiple SclerosisHaving higher numbers of particular gut microbes might put you at a higher risk of developing multiple sclerosis (MS), a new ...
A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...
Unusual fatigue or tingling could signal sclerosis. Learn the early signs, causes, and how to manage this misunderstood ...
A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...
A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed. A new artificial ...
Functional neurological disorder is one of the most common medical conditions seen in emergency care and in outpatient ...
Scientists in Sweden have taken an important step forward in understanding how a very common virus, called Epstein-Barr virus ...
Get Instant Summarized Text (Gist) An AI tool named MindGlide has been developed to assess the effectiveness of multiple sclerosis (MS) treatments by analyzing MRI brain scans. It can detect ...
10d
MedPage Today on MSNTolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple SclerosisSAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results